Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma

被引：0

作者：

Chiara Chiavelli

Malvina Prapa

Giulia Rovesti

Marco Silingardi

Giovanni Neri

Giuseppe Pugliese

Lucia Trudu

Massimiliano Dall’Ora

Giulia Golinelli

Giulia Grisendi

Jonathan Vinet

Marco Bestagno

Carlotta Spano

Roberto Vito Papapietro

Roberta Depenni

Katia Di Emidio

Anna Pasetto

Daniela Nascimento Silva

Alberto Feletti

Silvia Berlucchi

Corrado Iaccarino

Giacomo Pavesi

Massimo Dominici

机构：

[1] University of Modena and Reggio Emilia,Laboratory of Cellular Therapy, Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults

[2] University of Modena and Reggio Emilia,Clinical and Experimental Medicine PhD Program

[3] University-Hospital of Modena and Reggio Emilia,Department of Oncology and Hematology

[4] Great Maze Pond,Leucid Bio Ltd., Guy’s Hospital

[5] Evotec (Modena) Srl,Center for Cellular Immunotherapies

[6] Medolla,Centro Interdipartimentale Grandi Strumenti (CIGS)

[7] Perelman School of Medicine,Department of Biomedical, Metabolic and Neural Sciences

[8] and Parker Institute for Cancer Immunotherapy at University of Pennsylvania,Section for Cell Therapy, Radiumhospitalet

[9] University of Modena and Reggio Emilia,Department of Laboratory Medicine

[10] International Centre for Genetic Engineering and Biotechnology,Department of Neurosciences, Biomedicine and Movement Sciences, Neurosurgery Unit

[11] University of Modena and Reggio Emilia,Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia

[12] Oslo University Hospital, Division of Neurosurgery, Department of Neurosciences

[13] Karolinska Institutet,undefined

[14] University of Verona,undefined

[15] University-Hospital of Modena and Reggio Emilia,undefined

来源：

npj Precision Oncology | / 8卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Glioblastoma (GBM) remains a deadly tumor. Treatment with chemo-radiotherapy and corticosteroids is known to impair the functionality of lymphocytes, potentially compromising the development of autologous CAR T cell therapies. We here generated pre-clinical investigations of autologous anti-GD2 CAR T cells tested against 2D and 3D models of GBM primary cells. We detected a robust antitumor effect, highlighting the feasibility of developing an autologous anti-GD2 CAR T cell-based therapy for GBM patients.

引用

共 50 条

[31] Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Heczey, Andras
Xu, Xin
Courtney, Amy N.
Tian, Gengwen
Barragan, Gabriel A.
Guo, Linjie
Amador, Claudia Martinez
Ghatwai, Nisha
Rathi, Purva
Wood, Michael S.
Li, Yanchuan
Zhang, Chunchao
Demberg, Thorsten
Di Pierro, Erica J.
Sher, Andrew C.
Zhang, Huimin
Mehta, Birju
Thakkar, Sachin G.
Grilley, Bambi
Wang, Tao
Weiss, Brian D.
Montalbano, Antonino
Subramaniam, Meena
Xu, Chenling
Sachar, Chirag
Wells, Daniel K.
Dotti, Gianpietro
Metelitsa, Leonid S.
NATURE MEDICINE, 2023, 29 (06) : 1379 - +
[32] GENERATION OF CAR-NK CELLS ANTI-GD2 CO-EXPRESSING GITRL IN TUMOR MODELS OF NEUROECTODERMAL ORIGIN
Tirapelle, M. C.
Schmidt, D.
Ebrahimabadi, S.
Silvestre, R. N.
Covas, D. T.
Picanco e Castro, V.
CYTOTHERAPY, 2022, 24 (10) : S20 - S20
[33] Potent Anti-Tumor Effect Using T Cells Armed with Recombinant Anti-GD2 Bispecific Antibodies Against GD2 Positive Tumor
Nakajima, M.
Guo, H.
Hoseini, S. S.
Xu, H.
Cheung, N. K.
PEDIATRIC BLOOD & CANCER, 2018, 65 : S54 - S54
[34] ELIMINATION OF CAR-ENGINEERED LYMPHOCYTES BY AUTOLOGOUS ANTI-CAR T CELLS
Koristka, S.
Ziller-Walter, P.
Feldmann, A.
Arndt, C.
Kegler, A.
Albert, S.
Ehninger, G.
Bornhaeuser, M.
Bachmann, M.
HUMAN GENE THERAPY, 2018, 29 (11) : A9 - A9
[35] NKG2D-CAR Transduced Primary Natural Killer Cells Efficiently Target Multiple Myeloma Cells
Leivas, Alejandra
Rio, Paula
Mateos, Rebeca
Paciello, Mari Liz
Garcia-Ortiz, Almudena
Fernandez, Lucia
Perez-Martinez, Antonio
Lee, Dean Anthony
Powell, Daniel J., Jr.
Valeri, Antonio
Martinez-Lopez, Joaquin
BLOOD, 2018, 132
[36] Apoptosis is responsible for the cytotoxic effects of anti-GD2 ganglioside antibodies and aurora A kinase inhibitors on human neuroblastoma cells
Durbas, Malgorzata
Rokita, Hanna
Horwacik, Irena
Wisniewska, Aneta
Nowak, Iwona
ACTA BIOCHIMICA POLONICA, 2022, : 485 - 494
[37] HUMAN-IGM MONOCLONAL ANTI-GD2 ANTIBODY - REACTIVITY TO A HUMAN-MELANOMA XENOGRAFT
KATANO, M
SAXTON, RE
TSUCHIDA, T
IRIE, RF
JAPANESE JOURNAL OF CANCER RESEARCH, 1986, 77 (06): : 584 - 594
[38] Primary CD33-CAR-NK cells efficiently target acute myeloid leukemia
Albinger, N.
Pfeifer, R.
Nitsche, M.
Mertlitz, S.
Campe, J.
Stein, K.
Kreyenberg, H.
Schubert, R.
Quadflieg, M.
Schneider, D.
Kuehn, M. W.
Penack, O.
Zhang, C.
Moeker, N.
Ullrich, E.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 31 - 32
[39] Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Wehrli, Marc
Guinn, Samantha
Birocchi, Filippo
Kuo, Adam
Sun, Yi
Larson, Rebecca C.
Almazan, Antonio J.
Scarfo, Irene
Bouffard, Amanda A.
Bailey, Stefanie R.
Anekal, Praju Vikas
Montero Llopis, Paula
Nieman, Linda T.
Song, Yuhui
Xu, Katherine H.
Berger, Trisha R.
Kann, Michael C.
Leick, Mark B.
Silva, Harrison
Salas-Benito, Diego
Kienka, Tamina
Grauwet, Korneel
Armstrong, Todd D.
Zhang, Rui
Zhu, Qingfeng
Fu, Juan
Schmidts, Andrea
Korell, Felix
Jan, Max
Choi, Bryan D.
Liss, Andrew S.
Boland, Genevieve M.
Ting, David T.
Burkhart, Richard A.
Jenkins, Russell W.
Zheng, Lei
Jaffee, Elizabeth M.
Zimmerman, Jacquelyn W.
Maus, Marcela V.
CLINICAL CANCER RESEARCH, 2024, 30 (09) : 1859 - 1877
[40] Electrophysiological characteristics of primary afferent fibers after systemic administration of anti-GD2 ganglioside antibody
Xiao, WH
Yu, AL
Sorkin, LS
PAIN, 1997, 69 (1-2) : 145 - 151

← 1 2 3 4 5 →